Howard Schacter - Marimed Chief Officer
| MRMD Stock | USD 0.15 0.01 6.25% |
Insider
Howard Schacter is Chief Officer of Marimed
| Phone | 617 795 5140 |
| Web | https://www.marimedinc.com |
Marimed Management Efficiency
The company has return on total asset (ROA) of 0.0921 % which means that it generated a profit of $0.0921 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0303 %, meaning that it created $0.0303 on every $100 dollars invested by stockholders. Marimed's management efficiency ratios could be used to measure how well Marimed manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Jeff Finnerty | AYR Strategies Class | N/A | |
| Samuel Dorf | Verano Holdings Corp | N/A | |
| Stephan Bankosz | Vext Science | N/A | |
| Amber Shimpa | Goodness Growth Holdings | 44 | |
| Harris Rabin | Goodness Growth Holdings | 48 | |
| Jason Nguyen | Vext Science | N/A | |
| Christian Ocasio | Goodness Growth Holdings | 41 | |
| Jonathan Ross | Vext Science | N/A | |
| Todd Buchman | Cansortium | N/A | |
| Eric Offenberger | Vext Science | N/A | |
| Jennifer Drake | AYR Strategies Class | N/A | |
| Samantha Hymes | Cansortium | N/A | |
| Liora Boudin | Cansortium | N/A | |
| Buddy Wilson | Grown Rogue International | N/A | |
| JD III | Trulieve Cannabis Corp | 54 | |
| Robert Vanisko | AYR Strategies Class | N/A | |
| Ryan Kee | Grown Rogue International | 40 | |
| Swadheen Sehgal | Green Thumb Industries | N/A | |
| George Archos | Verano Holdings Corp | 44 | |
| Robert Beasley | Cansortium | N/A | |
| Adam August | Grown Rogue International | 45 | |
Management Performance
| Return On Equity | 0.0303 | |||
| Return On Asset | 0.0921 |
Marimed Leadership Team
Elected by the shareholders, the Marimed's board of directors comprises two types of representatives: Marimed inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Marimed. The board's role is to monitor Marimed's management team and ensure that shareholders' interests are well served. Marimed's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Marimed's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Timothy Shaw, Chief Officer | ||
| Steve West, VP Relations | ||
| Howard Schacter, Chief Officer | ||
| Sara Gullickson, VP Marketing | ||
| Susan CPA, Chief Officer | ||
| Jon Levine, President, CoFounder | ||
| Charles Finnie, Chief Officer | ||
| Ryan Crandall, VP Officer | ||
| Robert Fireman, Chairman CoFounder | ||
| Jonathan Rider, Chief Officer |
Marimed Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Marimed a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0303 | |||
| Return On Asset | 0.0921 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | 0.15 % | |||
| Current Valuation | 178.51 M | |||
| Shares Outstanding | 339.35 M | |||
| Shares Owned By Insiders | 17.90 % | |||
| Shares Owned By Institutions | 0.81 % | |||
| Price To Earning | 63.75 X | |||
| Price To Book | 2.96 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Marimed OTC Stock
Marimed financial ratios help investors to determine whether Marimed OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Marimed with respect to the benefits of owning Marimed security.